analyst
-
Financial
RTI Surgical (RTIX) Beats on Q4 Earnings and Revenues
RTI Surgical Inc. RTIX reported adjusted earnings of 9 cents per share in the fourth quarter of 2015, which beat the…
Read More » -
Financial
NuVasive (NUVA) Is in Oversold Territory: What’s Next?
NuVasive, Inc. NUVA has been on a bit of a cold streak lately, but there might be light at the end…
Read More » -
Financial
Is Intuitive Surgical (ISRG) Stock a Solid Choice Right Now?
One stock that might be an intriguing choice for investors right now is Intuitive Surgical, Inc. ISRG. This is because this…
Read More » -
Financial
Deutsche Bank Reiterates “Buy” Rating for ConforMIS Inc (CFMS)
ConforMIS Inc (NASDAQ:CFMS)‘s stock had its “buy” rating restated by equities research analysts at Deutsche Bank in a research note…
Read More » -
Financial
Oppenheimer Weighs in on Zimmer Biomet Holdings’ FY2015 Earnings (ZBH)
By Faye Duncan Oppenheimer boosted their FY2015 EPS estimates for shares of Zimmer Biomet Holdings (NYSE:ZBH) in a note issued…
Read More » -
Financial
Company Shares of Medtronic plc (NYSE:MDT) Drops by -0.57%
Medtronic plc (NYSE:MDT) has dropped 0.57% during the past week, however, the bigger picture is still very bullish; the shares…
Read More » -
Financial
Conmed Corporation (NASDAQ:CNMD): Can Conmed Corporation Hit Earnings Expectation Of $0.5?
Wall Street Analysts have given a mean estimate of $ 0.5 earnings per share to Conmed Corporation. This figure is…
Read More » -
Financial
Analysts Anticipate Histogenics Corp to Announce ($0.47) Earnings Per Share (NASDAQ:HSGX)
By Jennifer Langley Histogenics Corp (NASDAQ:HSGX) has received an average broker rating score of 1.50 (Buy) from the two brokers…
Read More » -
Financial
Zimmer Biomet Holdings Receives Average Rating of “Buy” from Analysts (NYSE:ZBH)
By Thomas Dobrow Zimmer Biomet Holdings (NYSE:ZBH) has earned a consensus rating of “Buy” from the seventeen research firms that…
Read More » -
Recon
MiMedx to Webcast Its Analyst Day on October 13, 2015
MARIETTA, Ga., Sept. 15, 2015 /PRNewswire/ — MiMedx Group, Inc. MDXG, +1.45%the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes…
Read More » -
Financial
CONMED CORPORATION (NASDAQ:CNMD) GIVEN RATING OF 2.29 BY ANALYSTS
CONMED Corporation (NASDAQ:CNMD) shares have been an average broker rating (ABR) of 2.29 at Zacks Research. This is based on…
Read More » -
Financial
Medtronic plc Analyst Rating Update
By Steve Hart Research firm Zacks has rated Medtronic plc (NYSE:MDT) and has ranked it at 4, indicating that for…
Read More » -
Financial
Oppenheimer: Time To Buy ConforMIS, Two Catalysts Are Coming Next Year Read more
By Monica Gerson In a report published Monday, Oppenheimer analyst Steven Lichtman initiated coverage of ConforMIS Inc CFMS 4.79% with an Outperform rating…
Read More » -
Financial
CONMED CORPORATION (NASDAQ:CNMD) ANALYST RATING UPDATE
Wall Street analysts polled by Zacks Research have given CONMED Corporation (NASDAQ:CNMD) a rating of 2 on a consensus basis.…
Read More » -
Financial
Analyst: ConMed ripe for M&A spree
By Fink Densford ConMed could be poised for some merger & acquisition activity as new management engineers a turnaround, according…
Read More »